Ophthalmology investors
5 investors that name Ophthalmology among their sectors are recorded here: 2 venture studios, 1 corporate venture arm, 1 public fund and 1 venture capital firm. Stated investment stages run from pre-seed to growth. Most are headquartered in France (2), the United Kingdom (1) and the United States (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| 82VS biotech · drug discovery · oncology · ophthalmology |
Direct investor | Venture studio | Series A | United States |
| Chugai Venture Fund, LLC Oncology · Immunology · CNS · Ophthalmology |
Direct investor | Corporate venture | Seed – Series A | |
| Discovery Park Ventures Advanced Manufacturing · Digital and AI · Cell and Gene therapies · Synthetic Biology |
Direct investor | Public fund | Seed | Sandwich, United Kingdom |
| Jeito Capital Biopharma · Oncology · Autoimmune · Ophthalmology |
Direct investor | Venture capital | Series A – Growth | Paris, France |
| M2care healthtech · medtech · cardiology · dermatology |
Direct investor | Venture studio | Pre-seed – Series A | Lyon, France |